Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639405 · ClinicalTrials.gov registry record
Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 12
- Enrollment target
NCT00639405: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.
NCT00639405 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639405 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-08 |
Why NCT00639405 stopped before completion
NCT00639405 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00639405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00639405 about?
NCT00639405 is a clinical study titled "Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas". The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.
What is the current status of trial NCT00639405?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2005-09. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00639405?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia